Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	HSPG2 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN	3.10e-10	188	105	12	GO:0005201
GeneOntologyMolecularFunction	sulfur compound binding	FBLN7 IMPG1 ACADM LAMC2 GCDH RCC1 THBS1 THBS2 THBS3 LIPG TAF1 AGRN	1.33e-07	323	105	12	GO:1901681
GeneOntologyMolecularFunction	serine-type endopeptidase activity	CTRC PRSS36 CD5L HPN PRSS45P MST1L KLK13	6.56e-05	190	105	7	GO:0004252
GeneOntologyMolecularFunction	heparin binding	FBLN7 IMPG1 LAMC2 THBS1 THBS2 THBS3 LIPG	7.00e-05	192	105	7	GO:0008201
GeneOntologyMolecularFunction	glycosaminoglycan binding	FBLN7 IMPG1 LAMC2 THBS1 THBS2 THBS3 LIPG AGRN	8.60e-05	268	105	8	GO:0005539
GeneOntologyMolecularFunction	serine-type peptidase activity	CTRC PRSS36 CD5L HPN PRSS45P MST1L KLK13	1.12e-04	207	105	7	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	CTRC PRSS36 CD5L HPN PRSS45P MST1L KLK13	1.30e-04	212	105	7	GO:0017171
GeneOntologyMolecularFunction	calcium ion binding	HSPG2 FBLN7 CLSTN3 DSG1 CRTAC1 CUBN DLL1 THBS1 THBS2 THBS3 LOXL2 AGRN RAB11FIP3	1.52e-04	749	105	13	GO:0005509
GeneOntologyMolecularFunction	structural molecule activity	HSPG2 IMPG1 EPB41L4B LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN MYBPC3	2.35e-04	891	105	14	GO:0005198
GeneOntologyMolecularFunction	collagen V binding	HSPG2 THBS1	2.71e-04	5	105	2	GO:0070052
GeneOntologyMolecularFunction	H3K27me3 modified histone binding	TAF1 TAF1L	2.71e-04	5	105	2	GO:0061628
GeneOntologyMolecularFunction	acyl-CoA binding	ACADM GCDH TAF1	3.36e-04	26	105	3	GO:0120227
GeneOntologyMolecularFunction	laminin binding	ADAM9 THBS1 AGRN	7.51e-04	34	105	3	GO:0043236
GeneOntologyMolecularFunction	sphingolipid binding	LAMB1 LAMC1 GLTPD2	7.51e-04	34	105	3	GO:0046625
GeneOntologyMolecularFunction	RNA polymerase I general transcription initiation factor activity	TAF1 TAF1L	9.63e-04	9	105	2	GO:0001181
GeneOntologyMolecularFunction	chondroitin sulfate binding	IMPG1 AGRN	1.46e-03	11	105	2	GO:0035374
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor	ACADM GCDH	1.75e-03	12	105	2	GO:0052890
GeneOntologyMolecularFunction	acyl-CoA dehydrogenase activity	ACADM GCDH	1.75e-03	12	105	2	GO:0003995
GeneOntologyMolecularFunction	endopeptidase activity	ADAM9 CTRC PRSS36 CD5L HPN PRSS45P MST1L KLK13	1.96e-03	430	105	8	GO:0004175
GeneOntologyMolecularFunction	glycosphingolipid binding	LAMB1 LAMC1	2.06e-03	13	105	2	GO:0043208
GeneOntologyBiologicalProcess	zymogen activation	THBS1 MELTF CD5L HPN CUZD1	2.11e-05	65	106	5	GO:0031638
GeneOntologyBiologicalProcess	protein localization to cleavage furrow	ARF6 RAB11FIP3	2.62e-05	2	106	2	GO:1905345
GeneOntologyBiologicalProcess	protein localization to cell division site	ARF6 RAB11FIP3	2.62e-05	2	106	2	GO:0072741
GeneOntologyBiologicalProcess	positive regulation of keratinocyte migration	EPB41L4B ADAM9 ARF6	3.63e-05	13	106	3	GO:0051549
GeneOntologyBiologicalProcess	regulation of keratinocyte migration	EPB41L4B ADAM9 ARF6	5.74e-05	15	106	3	GO:0051547
GeneOntologyBiologicalProcess	regulation of plasminogen activation	THBS1 MELTF HPN	1.02e-04	18	106	3	GO:0010755
GeneOntologyBiologicalProcess	extracellular matrix organization	HSPG2 CARMIL2 IMPG1 LAMB1 LAMC1 PAPLN MELTF HPN LOXL2	1.43e-04	377	106	9	GO:0030198
GeneOntologyBiologicalProcess	extracellular structure organization	HSPG2 CARMIL2 IMPG1 LAMB1 LAMC1 PAPLN MELTF HPN LOXL2	1.46e-04	378	106	9	GO:0043062
GeneOntologyBiologicalProcess	external encapsulating structure organization	HSPG2 CARMIL2 IMPG1 LAMB1 LAMC1 PAPLN MELTF HPN LOXL2	1.49e-04	379	106	9	GO:0045229
GeneOntologyBiologicalProcess	keratinocyte migration	EPB41L4B ADAM9 ARF6	1.64e-04	21	106	3	GO:0051546
GeneOntologyBiologicalProcess	cell junction assembly	CLSTN3 DSG1 ADGRB2 LAMC1 CRTAC1 CSMD2 ARF6 THBS1 THBS2 NRXN3 AGRN	1.67e-04	569	106	11	GO:0034329
GeneOntologyBiologicalProcess	synapse assembly	CLSTN3 ADGRB2 CRTAC1 CSMD2 ARF6 THBS2 NRXN3 AGRN	1.92e-04	308	106	8	GO:0007416
GeneOntologyCellularComponent	basement membrane	HSPG2 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 THBS2 LOXL2 AGRN	1.01e-08	122	104	9	GO:0005604
GeneOntologyCellularComponent	collagen-containing extracellular matrix	HSPG2 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 LOXL2 AGRN	2.30e-06	530	104	13	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	HSPG2 FBLN7 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 LOXL2 AGRN	4.60e-06	656	104	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	HSPG2 FBLN7 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 LOXL2 AGRN	4.76e-06	658	104	14	GO:0030312
GeneOntologyCellularComponent	laminin complex	LAMB1 LAMC1 LAMC2	1.40e-05	10	104	3	GO:0043256
GeneOntologyCellularComponent	laminin-2 complex	LAMB1 LAMC2	2.45e-05	2	104	2	GO:0005607
GeneOntologyCellularComponent	laminin-10 complex	LAMB1 LAMC1	7.33e-05	3	104	2	GO:0043259
GeneOntologyCellularComponent	laminin-1 complex	LAMB1 LAMC1	7.33e-05	3	104	2	GO:0005606
GeneOntologyCellularComponent	synaptic cleft	LAMA4 LAMC1 AGRN	5.86e-04	33	104	3	GO:0043083
GeneOntologyCellularComponent	cell surface	CLSTN3 ADAM9 NEU3 TNFRSF11A CUBN THBS1 MELTF CD5L KCNA4 LIPG HPN CUZD1 AGRN GP2	1.20e-03	1111	104	14	GO:0009986
MousePheno	abnormal compact bone morphology	HSPG2 CLSTN3 MCHR1 SMURF1 IRS1 TNFRSF11A THBS2 NOS2	1.24e-05	172	88	8	MP:0003797
Domain	EGF-like_dom	HSPG2 FBLN7 IMPG1 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 CRTAC1 CUBN DLL1 THBS1 THBS2 THBS3 NRXN3 AGRN GP2	6.13e-14	249	107	17	IPR000742
Domain	EGF_1	HSPG2 FBLN7 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 CRTAC1 CUBN DLL1 SSPOP THBS1 THBS2 THBS3 NRXN3 AGRN GP2	9.06e-14	255	107	17	PS00022
Domain	EGF-like_CS	HSPG2 FBLN7 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 CRTAC1 CUBN DLL1 THBS1 THBS2 THBS3 NRXN3 AGRN EPHA1 GP2	1.33e-13	261	107	17	IPR013032
Domain	EGF_2	HSPG2 FBLN7 ADAM9 LAMB1 LAMC1 LAMC2 CRTAC1 CUBN DLL1 SSPOP THBS1 THBS2 THBS3 NRXN3 AGRN EPHA1 GP2	1.70e-13	265	107	17	PS01186
Domain	EGF	HSPG2 FBLN7 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 CUBN DLL1 THBS1 THBS2 THBS3 NRXN3 AGRN	7.30e-11	235	107	14	SM00181
Domain	EGF_3	HSPG2 FBLN7 ADAM9 CRTAC1 CUBN DLL1 SSPOP THBS1 THBS2 THBS3 NRXN3 AGRN GP2	9.05e-10	235	107	13	PS50026
Domain	EGF_LAM_2	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	1.63e-08	30	107	6	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	1.63e-08	30	107	6	PS01248
Domain	EGF_CA	HSPG2 FBLN7 CRTAC1 CUBN DLL1 THBS1 THBS2 THBS3 AGRN	3.37e-08	122	107	9	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 FBLN7 CRTAC1 CUBN DLL1 THBS1 THBS2 THBS3 AGRN	3.88e-08	124	107	9	IPR001881
Domain	Laminin_G	HSPG2 LAMA4 THBS1 THBS2 THBS3 NRXN3 AGRN	3.93e-08	58	107	7	IPR001791
Domain	EGF_Lam	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	4.35e-08	35	107	6	SM00180
Domain	Laminin_EGF	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	4.35e-08	35	107	6	PF00053
Domain	-	HSPG2 CLSTN3 LAMA4 THBS1 THBS2 THBS3 NRXN3 AGRN	7.16e-08	95	107	8	2.60.120.200
Domain	Laminin_EGF	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	7.30e-08	38	107	6	IPR002049
Domain	TSP_1	THSD7A ADGRB2 PAPLN SSPOP THBS1 THBS2	1.60e-06	63	107	6	PF00090
Domain	TSP_3	THBS1 THBS2 THBS3	1.81e-06	5	107	3	PF02412
Domain	TSP3	THBS1 THBS2 THBS3	1.81e-06	5	107	3	PS51234
Domain	TSP_CTER	THBS1 THBS2 THBS3	1.81e-06	5	107	3	PS51236
Domain	Thrombospondin_3_rpt	THBS1 THBS2 THBS3	1.81e-06	5	107	3	IPR017897
Domain	TSP_type-3_rpt	THBS1 THBS2 THBS3	1.81e-06	5	107	3	IPR028974
Domain	-	THBS1 THBS2 THBS3	1.81e-06	5	107	3	4.10.1080.10
Domain	Thrombospondin_C	THBS1 THBS2 THBS3	1.81e-06	5	107	3	IPR008859
Domain	TSP_C	THBS1 THBS2 THBS3	1.81e-06	5	107	3	PF05735
Domain	Thrombospondin_3-like_rpt	THBS1 THBS2 THBS3	1.81e-06	5	107	3	IPR003367
Domain	TSP1	THSD7A ADGRB2 PAPLN SSPOP THBS1 THBS2	1.93e-06	65	107	6	SM00209
Domain	TSP1_rpt	THSD7A ADGRB2 PAPLN SSPOP THBS1 THBS2	1.93e-06	65	107	6	IPR000884
Domain	TSP1	THSD7A ADGRB2 PAPLN SSPOP THBS1 THBS2	1.93e-06	65	107	6	PS50092
Domain	Growth_fac_rcpt_	HSPG2 LAMB1 LAMC1 LAMC2 CUBN DLL1 THBS3 EPHA1	3.20e-06	156	107	8	IPR009030
Domain	ConA-like_dom	HSPG2 CLSTN3 LAMA4 THBS1 THBS2 THBS3 NRXN3 TRIM9 AGRN	4.71e-06	219	107	9	IPR013320
Domain	EGF	HSPG2 FBLN7 CUBN DLL1 THBS2 NRXN3 AGRN	8.02e-06	126	107	7	PF00008
Domain	EGF_CA	FBLN7 CRTAC1 CUBN THBS1 THBS2 THBS3	9.95e-06	86	107	6	PF07645
Domain	LAMININ_IVA	HSPG2 LAMC1 LAMC2	1.00e-05	8	107	3	PS51115
Domain	Laminin_B	HSPG2 LAMC1 LAMC2	1.00e-05	8	107	3	PF00052
Domain	LamB	HSPG2 LAMC1 LAMC2	1.00e-05	8	107	3	SM00281
Domain	Laminin_IV	HSPG2 LAMC1 LAMC2	1.00e-05	8	107	3	IPR000034
Domain	TFIID_sub1_DUF3591	TAF1 TAF1L	3.25e-05	2	107	2	IPR022591
Domain	TBP-binding	TAF1 TAF1L	3.25e-05	2	107	2	PF09247
Domain	DUF3591	TAF1 TAF1L	3.25e-05	2	107	2	PF12157
Domain	TAF_II_230-bd	TAF1 TAF1L	3.25e-05	2	107	2	IPR009067
Domain	-	TAF1 TAF1L	3.25e-05	2	107	2	1.10.1100.10
Domain	TAF1_animal	TAF1 TAF1L	3.25e-05	2	107	2	IPR011177
Domain	Peptidase_S1A	CTRC PRSS36 HPN PRSS45P MST1L KLK13	4.72e-05	113	107	6	IPR001314
Domain	TRYPSIN_DOM	CTRC PRSS36 HPN PRSS45P MST1L KLK13	5.21e-05	115	107	6	PS50240
Domain	Tryp_SPc	CTRC PRSS36 HPN PRSS45P MST1L KLK13	5.74e-05	117	107	6	SM00020
Domain	SEA	HSPG2 IMPG1 AGRN	6.36e-05	14	107	3	SM00200
Domain	VWFC_2	MUC19 SSPOP THBS1 THBS2	6.47e-05	38	107	4	PS50184
Domain	VWC	MUC19 SSPOP THBS1 THBS2	6.47e-05	38	107	4	SM00214
Domain	LAM_G_DOMAIN	HSPG2 LAMA4 NRXN3 AGRN	6.47e-05	38	107	4	PS50025
Domain	Trypsin_dom	CTRC PRSS36 HPN PRSS45P MST1L KLK13	6.92e-05	121	107	6	IPR001254
Domain	Trypsin	CTRC PRSS36 HPN PRSS45P MST1L KLK13	6.92e-05	121	107	6	PF00089
Domain	Peptidase_S1_PA	CTRC PRSS36 HPN PRSS45P MST1L KLK13	7.58e-05	123	107	6	IPR009003
Domain	VWF_dom	MUC19 SSPOP THBS1 THBS2	9.64e-05	42	107	4	IPR001007
Domain	LamG	HSPG2 LAMA4 NRXN3 AGRN	1.16e-04	44	107	4	SM00282
Domain	EGF_Ca-bd_CS	FBLN7 CRTAC1 CUBN DLL1 THBS3	2.38e-04	97	107	5	IPR018097
Domain	SEA	HSPG2 IMPG1 AGRN	2.60e-04	22	107	3	PF01390
Domain	EGF_CA	FBLN7 CRTAC1 CUBN DLL1 THBS3	2.62e-04	99	107	5	PS01187
Domain	TSPN	THBS1 THBS2 THBS3	2.98e-04	23	107	3	SM00210
Domain	SEA	HSPG2 IMPG1 AGRN	2.98e-04	23	107	3	PS50024
Domain	SEA_dom	HSPG2 IMPG1 AGRN	2.98e-04	23	107	3	IPR000082
Domain	TRYPSIN_HIS	CTRC PRSS36 HPN PRSS45P KLK13	3.15e-04	103	107	5	IPR018114
Domain	TRYPSIN_SER	CTRC PRSS36 HPN PRSS45P KLK13	3.60e-04	106	107	5	PS00135
Domain	TRYPSIN_HIS	CTRC PRSS36 HPN PRSS45P KLK13	3.76e-04	107	107	5	PS00134
Domain	-	CD5L HPN LOXL2	3.84e-04	25	107	3	3.10.250.10
Domain	SR	CD5L HPN LOXL2	3.84e-04	25	107	3	SM00202
Domain	SRCR-like_dom	CD5L HPN LOXL2	4.32e-04	26	107	3	IPR017448
Domain	SRCR_1	CD5L HPN LOXL2	4.32e-04	26	107	3	PS00420
Domain	SRCR_2	CD5L HPN LOXL2	4.32e-04	26	107	3	PS50287
Domain	SRCR	CD5L HPN LOXL2	4.84e-04	27	107	3	IPR001190
Domain	VWFC_1	SSPOP THBS1 THBS2	1.14e-03	36	107	3	PS01208
Domain	Acyl-CoA_DH_CS	ACADM GCDH	1.14e-03	9	107	2	IPR006089
Domain	ACYL_COA_DH_1	ACADM GCDH	1.42e-03	10	107	2	PS00072
Domain	ACYL_COA_DH_2	ACADM GCDH	1.42e-03	10	107	2	PS00073
Domain	Laminin_G_2	HSPG2 LAMA4 NRXN3	1.55e-03	40	107	3	PF02210
Domain	Acyl-CoA_dh_N	ACADM GCDH	1.73e-03	11	107	2	PF02771
Domain	Laminin_G_1	HSPG2 AGRN	1.73e-03	11	107	2	PF00054
Domain	TRYPSIN_SER	CTRC PRSS36 HPN KLK13	1.78e-03	90	107	4	IPR033116
Domain	EGF_dom	CUBN THBS2	2.07e-03	12	107	2	IPR024731
Domain	C8	MUC19 SSPOP	2.07e-03	12	107	2	PF08742
Domain	EGF_3	CUBN THBS2	2.07e-03	12	107	2	PF12947
Domain	TIL	MUC19 SSPOP	2.07e-03	12	107	2	PF01826
Domain	Galactose-bd-like	LAMB1 LAMC1 SSPOP EPHA1	2.09e-03	94	107	4	IPR008979
Domain	-	ACADM GCDH	2.43e-03	13	107	2	1.10.540.10
Domain	Acyl-CoA_dh_1	ACADM GCDH	2.43e-03	13	107	2	PF00441
Domain	AcylCoA_DH/ox_N	ACADM GCDH	2.43e-03	13	107	2	IPR013786
Domain	Unchr_dom_Cys-rich	MUC19 SSPOP	2.43e-03	13	107	2	IPR014853
Domain	C8	MUC19 SSPOP	2.43e-03	13	107	2	SM00832
Domain	ASX_HYDROXYL	FBLN7 CUBN DLL1 NRXN3	2.62e-03	100	107	4	PS00010
Domain	CUB	CUBN CSMD2 CUZD1	2.78e-03	49	107	3	PF00431
Domain	TIL_dom	MUC19 SSPOP	2.83e-03	14	107	2	IPR002919
Domain	ZP_2	CUZD1 GP2	2.83e-03	14	107	2	PS51034
Domain	ZP_1	CUZD1 GP2	2.83e-03	14	107	2	PS00682
Domain	CUB	CUBN CSMD2 CUZD1	2.95e-03	50	107	3	SM00042
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBLN7 CUBN DLL1 NRXN3	3.23e-03	106	107	4	IPR000152
Domain	Acyl-CoA_Oxase/DH_cen-dom	ACADM GCDH	3.25e-03	15	107	2	IPR006091
Domain	AcylCoA_DH/oxidase_NM_dom	ACADM GCDH	3.25e-03	15	107	2	IPR009100
Domain	-	IMPG1 AGRN	3.25e-03	15	107	2	3.30.70.960
Domain	Acyl-CoA_dh_M	ACADM GCDH	3.25e-03	15	107	2	PF02770
Domain	ZP	CUZD1 GP2	3.25e-03	15	107	2	SM00241
Domain	-	CUBN CSMD2 CUZD1	3.30e-03	52	107	3	2.60.120.290
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2 THBS3 SV2A AGRN	4.34e-11	84	81	10	M7098
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 THBS1 AGRN	4.26e-08	59	81	7	M27218
Pathway	REACTOME_LAMININ_INTERACTIONS	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2	7.04e-07	30	81	5	M27216
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	LAMB1 LAMC1 LAMC2 THBS1 THBS3	7.04e-07	30	81	5	M39641
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	LAMB1 LAMC1 LAMC2 THBS1 THBS3	7.04e-07	30	81	5	MM15812
Pathway	PID_INTEGRIN1_PATHWAY	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2	2.06e-06	66	81	6	M18
Pathway	REACTOME_SIGNALING_BY_MET	LAMA4 LAMB1 LAMC1 LAMC2 ARF6 HPN	5.94e-06	79	81	6	M27643
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	HSPG2 THSD7A GALNT12 SSPOP THBS1 THBS2 AGRN	1.77e-05	143	81	7	M27275
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	LAMA4 LAMB1 LAMC1 LAMC2	2.47e-05	30	81	4	M27772
Pathway	PID_INTEGRIN4_PATHWAY	LAMB1 LAMC1 LAMC2	2.92e-05	11	81	3	M158
Pathway	WP_ALPHA_6_BETA_4_SIGNALING	LAMB1 LAMC1 LAMC2 IRS1	3.65e-05	33	81	4	M39503
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	LAMB1 LAMC1 LAMC2 IRS1 RTKN	3.75e-05	66	81	5	MM15925
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	THSD7A MUC19 GALNT12 SSPOP THBS1 THBS2	3.77e-05	109	81	6	MM15164
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	THSD7A GALNT12 SSPOP THBS1 THBS2	4.34e-05	68	81	5	M27303
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	HSPG2 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 THBS1 LOXL2 AGRN	5.41e-05	300	81	9	M610
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	LAMA4 LAMB1 LAMC1 LAMC2 IRS1 THBS1 THBS2 THBS3 NOS2	5.69e-05	302	81	9	M39719
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A SSPOP THBS1 THBS2	7.14e-05	39	81	4	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A SSPOP THBS1 THBS2	7.14e-05	39	81	4	MM15165
Pathway	REACTOME_ECM_PROTEOGLYCANS	HSPG2 LAMA4 LAMB1 LAMC1 AGRN	7.42e-05	76	81	5	M27219
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	LAMA4 LAMB1 LAMC1 LAMC2	8.71e-05	41	81	4	M27778
Pathway	REACTOME_DISEASES_OF_METABOLISM	HSPG2 THSD7A GALNT12 CUBN SSPOP THBS1 THBS2 AGRN	9.21e-05	250	81	8	M27554
Pathway	WP_FOCAL_ADHESION	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2 THBS3	9.82e-05	187	81	7	MM15913
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	LAMA4 LAMB1 LAMC1 LAMC2 IRS1 THBS1 THBS2 THBS3 NOS2	1.02e-04	326	81	9	MM15917
Pathway	WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS	LAMA4 LAMC1 THBS1 THBS2	1.05e-04	43	81	4	M39565
Pathway	PID_INTEGRIN3_PATHWAY	LAMA4 LAMB1 LAMC1 THBS1	1.05e-04	43	81	4	M53
Pathway	KEGG_SMALL_CELL_LUNG_CANCER	LAMA4 LAMB1 LAMC1 LAMC2 NOS2	1.20e-04	84	81	5	M3228
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMA4 LAMB1 LAMC1 LAMC2	1.37e-04	46	81	4	M239
Pathway	WP_PI3KAKT_SIGNALING	LAMA4 LAMB1 LAMC1 LAMC2 IRS1 THBS1 THBS2 THBS3 PIK3R6	1.38e-04	339	81	9	M39736
Pathway	WP_FOCAL_ADHESION	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2 THBS3	1.45e-04	199	81	7	M39402
Pathway	KEGG_FOCAL_ADHESION	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2 THBS3	1.45e-04	199	81	7	M7253
Pathway	WP_SMALL_CELL_LUNG_CANCER	LAMA4 LAMB1 LAMC1 LAMC2 NOS2	2.25e-04	96	81	5	M39834
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	THSD7A GALNT12 SSPOP THBS1 THBS2	4.40e-04	111	81	5	M27416
Pathway	REACTOME_SIGNALING_BY_MST1	HPN MST1L	4.82e-04	6	81	2	MM15492
Pathway	PID_INTEGRIN_A4B1_PATHWAY	ARF6 THBS1 THBS2	8.81e-04	33	81	3	M277
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	LAMA4 LAMB1 LAMC1 LAMC2 IRS1 ARF6 THBS1 THBS2 THBS3 HPN	9.11e-04	532	81	10	M27870
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	HSPG2 ADAM9 LAMB1 LAMC1 LAMC2	1.26e-03	140	81	5	M587
Pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY	SMURF1 THBS1 THBS2 THBS3	1.50e-03	86	81	4	M2642
Pubmed	ERp57 is essential for efficient folding of glycoproteins sharing common structural domains.	LAMB1 LAMC1 LAMC2 MELTF LOXL2 AGRN	1.31e-10	25	108	6	17170699
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	HSPG2 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 THBS1 AGRN	1.44e-10	79	108	8	18757743
Pubmed	Basement membrane composition in the early mouse embryo day 7.	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2	7.70e-10	15	108	5	15895400
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	HSPG2 LAMA4 LAMB1 LAMC1 SSPOP THBS1 AGRN	1.23e-09	64	108	7	22261194
Pubmed	A new nomenclature for the laminins.	LAMA4 LAMB1 LAMC1 LAMC2	3.06e-09	7	108	4	7921537
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	THSD7A ADGRB2 PAPLN CUBN SSPOP THBS1 THBS2	3.81e-09	75	108	7	20637190
Pubmed	Trophoblast-specific expression and function of the integrin alpha 7 subunit in the peri-implantation mouse embryo.	LAMA4 LAMB1 LAMC1 LAMC2	1.82e-08	10	108	4	11784026
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA4 LAMB1 LAMC1 LAMC2	1.82e-08	10	108	4	9034910
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA4 LAMB1 LAMC1 LAMC2	2.85e-08	11	108	4	23472759
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA4 LAMB1 LAMC1 LAMC2	2.85e-08	11	108	4	21524702
Pubmed	mRNA Expression of thrombospondin 1, 2 and 3 from proximal to distal in human abdominal aortic aneurysm - preliminary report.	THBS1 THBS2 THBS3	2.91e-08	3	108	3	34669362
Pubmed	Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers.	THBS1 THBS2 THBS3	2.91e-08	3	108	3	1459996
Pubmed	Differential expression of thrombospondin 1, 2, and 3 during murine development.	THBS1 THBS2 THBS3	2.91e-08	3	108	3	8400410
Pubmed	Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system.	THBS1 THBS2 THBS3	2.91e-08	3	108	3	9373030
Pubmed	Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.	CACNA2D1 THBS1 THBS2	2.91e-08	3	108	3	19818485
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	HSPG2 LAMB1 LAMC1 LAMC2 AGRN	2.94e-08	29	108	5	22613833
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	HSPG2 LAMA4 LAMC1 AGRN	4.27e-08	12	108	4	16750824
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMA4 LAMB1 LAMC1 LAMC2	4.27e-08	12	108	4	9396756
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HSPG2 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 THBS1 AGRN	5.59e-08	167	108	8	22159717
Pubmed	Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane.	HSPG2 LAMB1 LAMC1 AGRN	6.15e-08	13	108	4	12682087
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	HSPG2 LAMA4 LAMB1 LAMC1 SSPOP THBS1 LOXL2 AGRN	8.03e-08	175	108	8	28071719
Pubmed	Platr4 is an early embryonic lncRNA that exerts its function downstream on cardiogenic mesodermal lineage commitment.	LAMA4 LAMC1 LAMC2 THBS1	8.59e-08	14	108	4	36347239
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	HSPG2 ADAM9 LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2 AGRN	8.73e-08	248	108	9	24006456
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	HSPG2 CENPB LAMA4 LAMB1 LAMC1 NRXN3 CDK11B AGRN PRRC2B	9.67e-08	251	108	9	28077445
Pubmed	Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets.	THBS1 THBS2 THBS3	1.16e-07	4	108	3	6338048
Pubmed	Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).	LAMA4 LAMB1 LAMC1	1.16e-07	4	108	3	24951930
Pubmed	Conjugation of LG domains of agrins and perlecan to polymerizing laminin-2 promotes acetylcholine receptor clustering.	HSPG2 LAMC2 AGRN	1.16e-07	4	108	3	16219760
Pubmed	Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.	LAMA4 LAMB1 LAMC1	1.16e-07	4	108	3	16146715
Pubmed	Laminin alpha5 chain is required for intestinal smooth muscle development.	LAMA4 LAMB1 LAMC1 LAMC2	1.17e-07	15	108	4	12921739
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMA4 LAMB1 LAMC1 LAMC2	1.55e-07	16	108	4	17601529
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 THBS2 AGRN	2.28e-07	135	108	7	28675934
Pubmed	Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.	LAMA4 LAMB1 LAMC1 LAMC2	2.60e-07	18	108	4	11311202
Pubmed	Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.	THBS1 THBS2 THBS3	2.90e-07	5	108	3	30622267
Pubmed	The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1.	HSPG2 LAMC1 AGRN	2.90e-07	5	108	3	7670489
Pubmed	Laminin gamma2 expression is developmentally regulated during murine tooth morphogenesis and is intense in ameloblasts.	LAMB1 LAMC1 LAMC2	2.90e-07	5	108	3	9719032
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	HSPG2 LAMA4 LAMB1 LAMC1 THBS1 THBS2 AGRN	3.89e-07	146	108	7	27068509
Pubmed	Laminin and integrin expression in the ventral ectodermal ridge of the mouse embryo: implications for regulation of BMP signalling.	LAMA4 LAMB1 LAMC1 LAMC2	4.10e-07	20	108	4	22911573
Pubmed	Protein profile of exosomes from trabecular meshwork cells.	HSPG2 LAMA4 LAMB1 LAMC1 THBS1	4.50e-07	49	108	5	21362503
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	HSPG2 LAMB1 LAMC1 THBS1 AGRN	4.99e-07	50	108	5	23658023
Pubmed	Schwann cell myelination requires integration of laminin activities.	HSPG2 LAMA4 LAMB1 LAMC1	5.05e-07	21	108	4	22767514
Pubmed	Expression and localization of laminin-5 subunits in the mouse incisor.	LAMB1 LAMC1 LAMC2	5.78e-07	6	108	3	9506922
Pubmed	Renal collecting system growth and function depend upon embryonic γ1 laminin expression.	HSPG2 LAMB1 LAMC1 AGRN	7.44e-07	23	108	4	21903675
Pubmed	Laminin isoforms in fetal and adult human adrenal cortex.	LAMA4 LAMB1 LAMC1	1.01e-06	7	108	3	14557481
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	LAMA4 LAMB1 LAMC1 LAMC2	1.25e-06	26	108	4	24742657
Pubmed	Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development.	HSPG2 LAMB1 LAMC1	1.61e-06	8	108	3	12015298
Pubmed	Expression and localization of laminin-5 subunits during mouse tooth development.	LAMB1 LAMC1 LAMC2	1.61e-06	8	108	3	9489770
Pubmed	Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear.	THBS1 THBS2 THBS3	1.61e-06	8	108	3	24460873
Pubmed	Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.	LAMB1 LAMC1 LAMC2	1.61e-06	8	108	3	8872465
Pubmed	Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis.	LAMB1 LAMC1 LAMC2	1.61e-06	8	108	3	23529140
Pubmed	Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro.	LAMA4 LAMB1 LAMC1	3.44e-06	10	108	3	18590826
Pubmed	Basement membrane distortions impair lung lobation and capillary organization in the mouse model for fraser syndrome.	LAMC1 LAMC2 AGRN	3.44e-06	10	108	3	15623520
Pubmed	Generation of a conditionally null allele of the laminin alpha1 gene.	HSPG2 LAMB1 LAMC1	3.44e-06	10	108	3	16100707
Pubmed	Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo.	HSPG2 LAMB1 LAMC1	3.44e-06	10	108	3	16554364
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	HKDC1 PAPLN LAMC2 CRTAC1 THBS1 THBS2 THBS3	4.41e-06	210	108	7	16537572
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	LAMA4 LAMB1 LAMC1 LAMC2	7.37e-06	40	108	4	27068110
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	HSPG2 THBS1 THBS2 THBS3 LOXL2	7.50e-06	86	108	5	28327460
Pubmed	The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut.	LAMA4 LAMB1 LAMC1	8.14e-06	13	108	3	36350252
Pubmed	Basement membranes in skin are differently affected by lack of nidogen 1 and 2.	HSPG2 LAMA4 LAMC1	8.14e-06	13	108	3	18356808
Pubmed	The γ3 chain of laminin is widely but differentially expressed in murine basement membranes: expression and functional studies.	HSPG2 LAMC1 LAMC2	8.14e-06	13	108	3	22222602
Pubmed	Induced thrombospondin expression in the mouse pancreas during pancreatic injury.	THBS1 THBS2	9.55e-06	2	108	2	16181801
Pubmed	Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations.	THBS1 THBS2	9.55e-06	2	108	2	17620335
Pubmed	Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.	HSPG2 AGRN	9.55e-06	2	108	2	25506919
Pubmed	cDNA cloning, expression and mapping of human laminin B2 gene to chromosome 1q31.	LAMB1 LAMC1	9.55e-06	2	108	2	3402995
Pubmed	Compound deletion of thrombospondin-1 and -2 results in a skeletal phenotype not predicted by the single gene knockouts.	THBS1 THBS2	9.55e-06	2	108	2	34425286
Pubmed	Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells.	THBS1 THBS2	9.55e-06	2	108	2	8126073
Pubmed	A novel disulfide pattern in laminin-type epidermal growth factor-like (LE) modules of laminin β1 and γ1 chains.	LAMB1 LAMC1	9.55e-06	2	108	2	20731416
Pubmed	Restricted localization of thrombospondin-2 protein during mouse embryogenesis: a comparison to thrombospondin-1.	THBS1 THBS2	9.55e-06	2	108	2	9694593
Pubmed	Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.	TAF1 TAF1L	9.55e-06	2	108	2	38804708
Pubmed	Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.	THBS1 THBS2	9.55e-06	2	108	2	10027393
Pubmed	Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype.	THBS2 THBS3	9.55e-06	2	108	2	11943589
Pubmed	Sustained expression of a neuron-specific isoform of the Taf1 gene in development stages and aging in mice.	TAF1 TAF1L	9.55e-06	2	108	2	22842574
Pubmed	Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3.	THBS1 THBS3	9.55e-06	2	108	2	8654563
Pubmed	Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.	TAF1 TAF1L	9.55e-06	2	108	2	27571988
Pubmed	Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues.	THBS2 THBS3	9.55e-06	2	108	2	10329465
Pubmed	Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.	TAF1 TAF1L	9.55e-06	2	108	2	34403156
Pubmed	Contribution of Thrombospondin-1 and -2 to Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.	THBS1 THBS2	9.55e-06	2	108	2	33981184
Pubmed	Agrin binds to the nerve-muscle basal lamina via laminin.	LAMB1 AGRN	9.55e-06	2	108	2	9151673
Pubmed	TSP1 and TSP2 Have Unique and Overlapping Roles in Protecting against Noise-Induced Auditory Synaptopathy.	THBS1 THBS2	9.55e-06	2	108	2	30928339
Pubmed	Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.	THBS1 THBS2	9.55e-06	2	108	2	17143334
Pubmed	Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes.	THBS1 THBS2	9.55e-06	2	108	2	23660684
Pubmed	Computational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linking.	LAMB1 LAMC1	9.55e-06	2	108	2	20939100
Pubmed	Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscle.	IRS1 NOS2	9.55e-06	2	108	2	21206533
Pubmed	Increased excitatory connectivity and epileptiform activity in thrombospondin1/2 knockout mice following cortical trauma.	THBS1 THBS2	9.55e-06	2	108	2	39122122
Pubmed	Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures.	THBS1 THBS2	9.55e-06	2	108	2	22930728
Pubmed	THBS1 and THBS2 Enhance the In Vitro Proliferation, Adhesion, Migration and Invasion of Intrahepatic Cholangiocarcinoma Cells.	THBS1 THBS2	9.55e-06	2	108	2	38339060
Pubmed	Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Temporal Lobe Epilepsy Before and After Surgery.	THBS1 THBS2	9.55e-06	2	108	2	33372257
Pubmed	An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.	THBS1 THBS2	9.55e-06	2	108	2	21762961
Pubmed	Agrin and synaptic laminin are required to maintain adult neuromuscular junctions.	LAMA4 AGRN	9.55e-06	2	108	2	23056392
Pubmed	The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice.	THBS1 THBS2	9.55e-06	2	108	2	12213711
Pubmed	Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiology.	LAMB1 THBS2	9.55e-06	2	108	2	30920297
Pubmed	Thrombospondin expression in aldosterone-producing adenomas.	THBS1 THBS2	9.55e-06	2	108	2	12358136
Pubmed	A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome.	THBS1 THBS2	9.55e-06	2	108	2	1712771
Pubmed	Molecular characterization of Rab11-FIP3 binding to ARF GTPases.	ARF6 RAB11FIP3	9.55e-06	2	108	2	17628206
Pubmed	TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin.	TAF1 TAF1L	9.55e-06	2	108	2	10070062
Pubmed	Thrombospondin 3 is a developmentally regulated heparin binding protein.	THBS1 THBS3	9.55e-06	2	108	2	8288588
Pubmed	Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke.	THBS1 THBS2	9.55e-06	2	108	2	18594557
Pubmed	Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.	THBS1 THBS2	9.55e-06	2	108	2	15037577
Pubmed	Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].	CUZD1 GP2	9.55e-06	2	108	2	25968583
Pubmed	Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors.	THBS1 THBS2	9.55e-06	2	108	2	33759165
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CENPB ZNF316 LAMB1 GCDH SUCLG1 METTL13 SF3B3 SV2A HPN TAF1 ANKRD52 PRRC2B BAHCC1 ZNF646	9.57e-06	1116	108	14	31753913
Interaction	CFC1 interactions	CLSTN3 ADAM9 LAMB1 LAMC1 PAPLN GALNT12 THBS1 LOXL2 AGRN	2.16e-08	126	106	9	int:CFC1
Interaction	LY86 interactions	CLSTN3 ADAM9 LAMB1 NEU3 LAMC1 RTKN THBS1 MELTF LOXL2	2.19e-06	217	106	9	int:LY86
Interaction	PI15 interactions	HSPG2 LAMC1 GALNT12 THBS1 LOXL2 AGRN	4.99e-06	83	106	6	int:PI15
Interaction	NID2 interactions	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 AGRN	6.14e-06	86	106	6	int:NID2
Interaction	SIRPD interactions	HSPG2 ADAM9 GALNT12 THBS1 MELTF LOXL2	6.14e-06	86	106	6	int:SIRPD
Interaction	SDF2L1 interactions	HSPG2 CLSTN3 ADAM9 LAMB1 LAMC1 PAPLN GALNT12 MELTF LOXL2 AGRN	7.75e-06	322	106	10	int:SDF2L1
Interaction	PYHIN1 interactions	HSPG2 CENPB LAMA4 LAMB1 LAMC1 NRXN3 CDK11B AGRN PRRC2B ZNF646	1.94e-05	358	106	10	int:PYHIN1
Interaction	PRG2 interactions	HSPG2 CLSTN3 ADAM9 LAMC1 LAMC2 GALNT12 THBS1 MELTF LOXL2	1.98e-05	285	106	9	int:PRG2
Interaction	LYZL1 interactions	CACNA2D1 ADAM9 LAMC1 GALNT12 THBS1 STS	3.76e-05	118	106	6	int:LYZL1
Interaction	IGFL3 interactions	CACNA2D1 ADAM9 LAMB1 LOXL2 AGRN	4.72e-05	75	106	5	int:IGFL3
Interaction	FBXO2 interactions	HSPG2 CACNA2D1 ADAM9 LAMA4 LAMB1 LAMC1 LAMC2 LOXL2 AGRN EPHA1	6.23e-05	411	106	10	int:FBXO2
Interaction	ELSPBP1 interactions	ADAM9 GALNT12 MELTF LOXL2 AGRN	1.25e-04	92	106	5	int:ELSPBP1
Interaction	THBS2 interactions	THBS1 THBS2 THBS3	1.29e-04	19	106	3	int:THBS2
GeneFamily	Laminin subunits	LAMA4 LAMB1 LAMC1 LAMC2	6.08e-08	12	62	4	626
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 AGRN	2.40e-04	7	62	2	570
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY10 ADCY5	5.12e-04	10	62	2	53
GeneFamily	Acyl-CoA dehydrogenase family	ACADM GCDH	6.24e-04	11	62	2	974
GeneFamily	Proteases, serine	PRSS36 HPN PRSS45P	1.32e-03	63	62	3	738
Coexpression	NABA_CORE_MATRISOME	HSPG2 FBLN7 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN VWA5B1	6.37e-12	270	108	14	MM17057
Coexpression	NABA_CORE_MATRISOME	HSPG2 FBLN7 IMPG1 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN VWA5B1	8.15e-12	275	108	14	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	FBLN7 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN VWA5B1	2.40e-11	191	108	12	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	FBLN7 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 AGRN VWA5B1	3.25e-11	196	108	12	M3008
Coexpression	NABA_BASEMENT_MEMBRANES	HSPG2 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 AGRN	2.76e-10	40	108	7	M5887
Coexpression	NABA_MATRISOME	HSPG2 FBLN7 IMPG1 ADAM9 MUC19 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 LOXL2 PLXNA4 MST1L AGRN VWA5B1	2.85e-08	1008	108	19	MM17056
Coexpression	NABA_MATRISOME	HSPG2 FBLN7 IMPG1 ADAM9 MUC19 LAMA4 LAMB1 LAMC1 PAPLN LAMC2 SSPOP THBS1 THBS2 THBS3 LOXL2 PLXNA4 MST1L AGRN VWA5B1	3.77e-08	1026	108	19	M5889
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	HSPG2 ABCA4 LAMB1 LAMC2 GCDH CUBN THBS2 THBS3 LOXL2 TAF1 AP4M1 MYBPC3	7.37e-07	482	108	12	M12144
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR	ADAM9 PAPLN THBS2 LOXL2 AGRN	4.54e-06	59	108	5	M47989
Coexpression	VERRECCHIA_RESPONSE_TO_TGFB1_C4	LAMB1 THBS1 THBS2	1.10e-05	11	108	3	M566
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	THSD7A SMURF1 MUC19 LAMC2 GALNT12 CSMD2 SSPOP PPARGC1B NOL4L CMIP NRXN3 TRIM9 SV2A SCN3A PLXNA4 PRRC2B	1.20e-05	1106	108	16	M39071
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	MCHR1 ETV2 LAMA4 PAPLN PRSS36 MELTF	2.17e-05	136	108	6	M2005
Coexpression	NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER	ADAM9 PAPLN LOXL2 AGRN	2.45e-05	41	108	4	M47988
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL3	THSD7A ADAM9 ADGRB2 MUC19 PAPLN HEATR5A IRS1 SSPOP GAREM2 TRIM9 LIPG	2.56e-05	574	108	11	M39056
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	MCHR1 ETV2 LAMA4 PAPLN PRSS36 MELTF	3.23e-05	146	108	6	MM856
Coexpression	GOZGIT_ESR1_TARGETS_UP	CLSTN3 THSD7A LAMB1 LAMC1 DUSP19 STS	3.62e-05	149	108	6	M13944
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	HSPG2 ADAM9 LAMA4 LAMB1 LAMC1 THBS2	5.78e-05	162	108	6	M45037
Coexpression	NABA_MATRISOME_BLEO_FIBROTIC_LUNG	HSPG2 LAMC1 LAMC2	7.37e-05	20	108	3	MM17053
Coexpression	DELYS_THYROID_CANCER_UP	LAMC2 GALNT12 THBS1 THBS2 SV2A HPN LOXL2 KLHDC8A AGRN	9.59e-05	445	108	9	M3645
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	HSPG2 LAMC1 LAMC2	1.13e-04	23	108	3	M48001
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL	HSPG2 ADAM9 LAMB1 HPDL THBS1 NRXN3 LOXL2	1.25e-04	268	108	7	M45796
Coexpression	GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	THSD7A FSCN3 ADGRB2 IRS1 ARF6 RAB11FIP3	1.65e-04	196	108	6	M8147
Coexpression	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN	HSPG2 TEX2 LAMA4 GCDH THBS3 HPN	1.79e-04	199	108	6	M3653
Coexpression	NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED	ADAM9 LOXL2 AGRN	2.30e-04	29	108	3	M47987
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200	CACNA2D1 SYNPO2 LAMA4 THBS1 THBS2 NRXN3 AGRN	1.97e-05	164	107	7	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500	LAMA4 LAMB1 LAMC1 LAMC2 CHD7 DLL1 AGRN	2.05e-05	165	107	7	gudmap_kidney_P4_CapMesRenVes_Crym_k3_500
CoexpressionAtlas	JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1	HSPG2 CACNA2D1 FBLN7 ABCA4 THSD7A LAMA4 LAMB1 LAMC1 CRTAC1 TNFRSF11A CUBN THBS1 STS LOXL2 PLXNA4	7.01e-05	936	107	15	JC_hmvEC_2500_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#1_top-relative-expression-ranked_200	CACNA2D1 SYNPO2 LAMA4 THBS2 NRXN3	7.45e-05	86	107	5	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k1
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100	SYNPO2 LAMA4 THBS1 THBS2 NRXN3	7.45e-05	86	107	5	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 TNFRSF11A THBS1 LOXL2 PLXNA4 AGRN	7.58e-05	439	107	10	GSM777059_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	HSPG2 CACNA2D1 SYNPO2 ADAM9 LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2	8.48e-05	445	107	10	GSM777043_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500	CACNA2D1 SYNPO2 LAMA4 ADCY5 THBS2	9.75e-05	91	107	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000	CACNA2D1 LAMA4 LAMC1 ADCY5 THBS1 THBS2	1.09e-04	149	107	6	gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	HSPG2 LAMA4 LAMB1 LAMC1 THBS1	1.32e-04	97	107	5	GSM777043_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	CACNA2D1 LAMA4 LAMC1 NOL4L AGRN PRRC2B ZNF646 RAB11FIP3	1.84e-04	312	107	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500	CACNA2D1 SYNPO2 LAMA4 THBS1 THBS2	1.91e-04	105	107	5	gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2
CoexpressionAtlas	ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_500	CARMIL2 EPB41L4B PAPLN TNFRSF11A HPDL PPARGC1B PIK3R6 CUZD1 KLK13 EPHA1	1.99e-04	494	107	10	PCBC_ratio_SC_vs_EB_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	CACNA2D1 SYNPO2 THSD7A ZNF316 LAMA4 LAMC1 ADCY5 NOL4L SCN3A AGRN PRRC2B ZNF646 RAB11FIP3	2.08e-04	806	107	13	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	ASRGL1 TEX2 ADAM9 LAMB1 HKDC1 NEU3 LAMC1 IRS1 CUBN SUCLG1 SLC10A1 LIPG HPN ENTPD5 GLTPD2	2.45e-04	1049	107	15	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200	LAMA4 LAMC1 LAMC2 CHD7	2.72e-04	62	107	4	gudmap_kidney_P4_CapMesRenVes_Crym_k3_200
CoexpressionAtlas	Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4	HSPG2 LAMA4 LAMB1 LAMC1 IRS1 THBS1 THBS2 THBS3 LOXL2	3.69e-04	437	107	9	GSM777046_500
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2 SCN3A	2.23e-08	191	108	8	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 THSD7A LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2	2.32e-08	192	108	8	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 THSD7A LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2	2.32e-08	192	108	8	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4\|TCGA-Lung / Sample_Type by Project: Shred V9	MCHR1 LAMB1 THBS1 THBS2 LIPG PLXNA4 LILRA4	1.81e-07	168	108	7	aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	CACNA2D1 FBLN7 LAMA4 TNFRSF11A SV2A LOXL2 SCN3A	2.13e-07	172	108	7	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLSTN3 THSD7A LAMA4 LAMC1 TNFRSF11A RTKN THBS2	3.01e-07	181	108	7	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLSTN3 THSD7A LAMA4 LAMC1 TNFRSF11A RTKN THBS2	3.01e-07	181	108	7	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLSTN3 THSD7A LAMA4 LAMC1 TNFRSF11A RTKN THBS2	3.01e-07	181	108	7	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 ETV2 LAMB1 PAPLN ADCY5 THBS2 THBS3	3.48e-07	185	108	7	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 ETV2 LAMB1 PAPLN ADCY5 THBS2 THBS3	3.48e-07	185	108	7	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 ETV2 LAMB1 PAPLN ADCY5 THBS2 THBS3	3.48e-07	185	108	7	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMB1 LAMC1 PAPLN CSMD2 DLL1 LOXL2	3.88e-07	188	108	7	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 FBLN7 THSD7A ADAM9 LAMB1 THBS2 TRIM9	4.03e-07	189	108	7	1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 FBLN7 THSD7A ADAM9 LAMB1 THBS2 TRIM9	4.03e-07	189	108	7	bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	4.03e-07	189	108	7	bc54ffd7bd1627a36747a80ce5139e4a69928400
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 FBLN7 THSD7A ADAM9 LAMB1 THBS2 TRIM9	4.03e-07	189	108	7	14833feea8f80744a06ece73f813eaeff8c4dd61
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	4.17e-07	190	108	7	f3ca94a31a35eed5fecf3c4b8c957e1bc4150158
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	4.17e-07	190	108	7	c2cd1eb674162ee40502c3380b7245c85079c7ce
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 CACNA2D1 LAMA4 LAMB1 KLHDC8A NOS2 AGRN	4.32e-07	191	108	7	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	facs-Pancreas-Exocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 CTRC LAMA4 HPN CUZD1 AGRN GP2	4.64e-07	193	108	7	c3161a14a40323a58aa202c8a1d6ea0e9c2b9814
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS1 THBS3 LOXL2	5.14e-07	196	108	7	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS1 THBS3 LOXL2	5.14e-07	196	108	7	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	CACNA2D1 LAMA4 LAMB1 LAMC1 CSMD2 THBS1 THBS2	5.32e-07	197	108	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA2D1 LAMA4 LAMB1 LAMC1 THBS1 THBS2 PLXNA4	5.51e-07	198	108	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	CACNA2D1 SYNPO2 LAMA4 LAMB1 IRS1 THBS1 PLXNA4	5.89e-07	200	108	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 LAMA4 LAMB1 LAMC1 THBS1 THBS2 LOXL2	5.89e-07	200	108	7	38190e4b32f7469df1da7d130bca6d7b12a3dd06
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	EPB41L4B FSCN3 CRTAC1 SLC10A1 GAREM2 EPHA1	1.31e-06	142	108	6	4ac3b285adfe80c47861943cf8c6188106cb3ba8
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ETV2 C1orf167 RTKN MELTF PIK3R6 TRIM9	2.17e-06	155	108	6	335cd798afbaa0a3a3e1dc558a81cfa32da48983
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 THSD7A LAMA4 LAMB1 THBS1 LOXL2	3.58e-06	169	108	6	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FBLN7 LAMC1 PPARGC1B PRRC2B RAB11FIP3	4.10e-06	173	108	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FBLN7 LAMC1 PPARGC1B PRRC2B RAB11FIP3	4.10e-06	173	108	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 THSD7A LAMA4 LAMB1 THBS1 LOXL2	4.52e-06	176	108	6	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 THSD7A LAMA4 LAMB1 THBS1 LOXL2	4.52e-06	176	108	6	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 THSD7A CRTAC1 CUBN CMIP KLK13	4.67e-06	177	108	6	d68132e145bd413404fdbe215b5dbe520e756e50
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA2D1 SYNPO2 LAMB1 IRS1 THBS2 PLXNA4	5.15e-06	180	108	6	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 SYNPO2 LAMB1 PAPLN ADCY5 THBS2	5.31e-06	181	108	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	RV\|World / Chamber and Cluster_Paper	SYNPO2 LAMA4 ASB15 ADCY5 PPARGC1B MYBPC3	5.31e-06	181	108	6	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 LAMB1 LAMC1 DLL1 NOS2 AGRN	5.48e-06	182	108	6	997d37ca2af661c92a56add888762724dfccc890
ToppCell	facs-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTRC LAMA4 HPN CUZD1 AGRN GP2	5.48e-06	182	108	6	45faefd7cbeac84d2c58650530b902af6ce921f8
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 SYNPO2 LAMB1 LAMC1 THBS2 TRIM9	5.48e-06	182	108	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	wk_20-22-Epithelial-PNS-intermediate_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HSPG2 THSD7A EPB41L4B CSMD2 KRBA1 NRXN3	5.84e-06	184	108	6	4e3ba64692868563a579902aa9c6f88cab5bce26
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA2D1 MCHR1 HEATR5A CUBN THBS3 PLXNA4	6.02e-06	185	108	6	ef996f4cdbc3971c6c0460d13df64b075ab22154
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA2D1 MCHR1 HEATR5A CUBN THBS3 PLXNA4	6.02e-06	185	108	6	d51342a3979bd728a80e04126059a3fd8a0dbe3b
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNPO2 IRS1 THBS1 THBS2 TRIM9 PLXNA4	6.02e-06	185	108	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	CACNA2D1 SYNPO2 ADCY5 THBS1 THBS2 PLXNA4	6.40e-06	187	108	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA2D1 LAMA4 LAMB1 LAMC1 THBS1 TRIM9	6.40e-06	187	108	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD7A LAMA4 RTKN THBS2 NRXN3 LOXL2	7.01e-06	190	108	6	e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 KCNA4 TRIM9 KLHDC8A SCN3A GP2	7.01e-06	190	108	6	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 KCNA4 TRIM9 KLHDC8A SCN3A GP2	7.01e-06	190	108	6	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD7A LAMA4 RTKN THBS2 NRXN3 LOXL2	7.01e-06	190	108	6	f32d66c0e74e0a2a23ecb857c4daf0d8573a806c
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 ABCA4 LAMA4 LAMB1 CUBN PPARGC1B	7.01e-06	190	108	6	06bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD7A LAMA4 RTKN THBS2 NRXN3 LOXL2	7.01e-06	190	108	6	b79ffd05806244a9790cd04c66fb4f92c824e69f
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 KCNA4 TRIM9 KLHDC8A SCN3A GP2	7.01e-06	190	108	6	a9a705455019e28d655636de73b07540798f82e6
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNA2D1 SYNPO2 LAMA4 LAMB1 THBS1 THBS2	7.01e-06	190	108	6	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SYNPO2 LAMC1 THBS1 THBS2 THBS3 LOXL2	7.23e-06	191	108	6	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYNPO2 LAMA4 THBS1 THBS2 LIPG LOXL2	7.23e-06	191	108	6	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS3 LOXL2	7.45e-06	192	108	6	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS3 LOXL2	7.45e-06	192	108	6	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM9 LAMA4 LAMB1 LAMC1 THBS3 LOXL2	7.45e-06	192	108	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 LAMA4 LAMB1 IRS1 CMIP LOXL2	7.67e-06	193	108	6	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS3 LOXL2	7.67e-06	193	108	6	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 LAMB1 LAMC1 THBS1 THBS3 LOXL2	7.67e-06	193	108	6	160691b671710be10220803d788c2c961c236af1
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CACNA2D1 LAMA4 LAMB1 CSMD2 THBS1 THBS2	7.90e-06	194	108	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	facs-SCAT-Fat-3m-Mesenchymal\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	7.90e-06	194	108	6	14b614f039bc866a1348a2728a68b7d254c7748c
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN7 LAMB1 LAMC1 THBS2 NRXN3 LOXL2	7.90e-06	194	108	6	415801a3dfacf05f2b603fb424df3d045190a812
ToppCell	facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	7.90e-06	194	108	6	68c7bfead1158641928cc276f599b4a79e06c73c
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 ABCA4 LAMB1 LIPG LOXL2 AGRN	7.90e-06	194	108	6	8a4be91414a2e69dd410aa75791f16008204c9a1
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN7 LAMB1 LAMC1 THBS2 NRXN3 LOXL2	7.90e-06	194	108	6	256cb33ec90328f2704921fb0fe0fd9812e138b0
ToppCell	facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA4 LAMB1 LAMC1 THBS2 THBS3 LOXL2	7.90e-06	194	108	6	f6aeae6a1e4017e341323fd4784c9e3bae00552b
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN7 LAMB1 LAMC1 THBS2 NRXN3 LOXL2	7.90e-06	194	108	6	7942bc83c1bdca687795b91aa232824d603f9b09
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	LAMA4 LAMB1 PPARGC1B THBS1 THBS2 PLXNA4	8.14e-06	195	108	6	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 LAMA4 LAMB1 THBS1 THBS3 LOXL2	8.14e-06	195	108	6	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMC1 DLL1 THBS1 CMIP LOXL2	8.38e-06	196	108	6	85507488f83d8f71b3ee2ad5e5aa0b6ad6193873
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMB1 LAMC1 PAPLN DLL1 LOXL2 PLXNA4	8.38e-06	196	108	6	1bcae4e0a244af822e2b12b2026a2771316f107d
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMB1 LAMC1 PAPLN DLL1 LOXL2	8.62e-06	197	108	6	ea746772adb9df4ddb0508d4ef35f2027bf09c35
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA2D1 LAMA4 LAMB1 CSMD2 THBS1 THBS2	8.62e-06	197	108	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 PLXNA4	8.62e-06	197	108	6	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA4 LAMB1 THBS1 THBS2 LOXL2 PLXNA4	8.62e-06	197	108	6	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYNPO2 THBS1 THBS2 THBS3 NRXN3 PLXNA4	8.62e-06	197	108	6	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 PLXNA4	8.62e-06	197	108	6	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HSPG2 LAMA4 LAMB1 LAMC1 THBS2 PLXNA4	8.62e-06	197	108	6	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA4 LAMB1 THBS1 THBS2 LOXL2 PLXNA4	8.62e-06	197	108	6	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	distal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 IRS1 CSMD2 THBS2 TRIM9 PLXNA4	8.87e-06	198	108	6	dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMB1 LAMC1 DLL1 CMIP LOXL2	8.87e-06	198	108	6	09be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 LAMB1 LAMC1 THBS3 LOXL2	8.87e-06	198	108	6	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HSPG2 ABCA4 LAMC2 GALNT12 HEATR5A NRXN3	8.87e-06	198	108	6	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNPO2 LAMA4 LAMB1 LAMC1 ADCY5 LOXL2	8.87e-06	198	108	6	dc6d9032c5029527e184ac13b887c0c1f22ef1c0
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2 LAMA4 LAMB1 THBS1 THBS2 LOXL2	8.87e-06	198	108	6	a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FSCN3 CSMD2 THBS3 KCNA4 TRIM9 KLHDC8A	8.87e-06	198	108	6	0cd930e374c2c48d1991b51c025f9801b22ecee7
ToppCell	distal-mesenchymal-Fibromyocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 IRS1 CSMD2 THBS2 TRIM9 PLXNA4	8.87e-06	198	108	6	9d1d95e7703cfc70a8ad427e400c340dbd205db8
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 LAMA4 LAMB1 LAMC1 CMIP LOXL2	8.87e-06	198	108	6	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	distal-mesenchymal-Fibromyocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYNPO2 IRS1 CSMD2 THBS2 TRIM9 PLXNA4	8.87e-06	198	108	6	fbfac1d10e4224990a094cc84b74bbc206881423
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FSCN3 CSMD2 THBS3 KCNA4 TRIM9 KLHDC8A	8.87e-06	198	108	6	e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMB1 LAMC1 DLL1 THBS2 LOXL2	9.13e-06	199	108	6	30ab0750d51f168b18c434c974d24a4e70f29cc7
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 LAMA4 LAMB1 LAMC1 CRTAC1 THBS2	9.13e-06	199	108	6	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 LAMA4 LAMB1 LAMC1 LOXL2 AGRN	9.13e-06	199	108	6	463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMB1 LAMC1 DLL1 CMIP LOXL2	9.13e-06	199	108	6	bdedcc7c8f3be0996200c882dda82fb2658655c0
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAM9 LAMA4 LAMB1 LAMC1 THBS1 PLXNA4	9.40e-06	200	108	6	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	SYNPO2 LAMA4 LAMB1 IRS1 ADCY5 LIPG	9.40e-06	200	108	6	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|Endothelial_cells / Location, Cell class and cell subclass	HSPG2 LAMB1 LAMC1 THBS1 CMIP AGRN	9.40e-06	200	108	6	9c1b30fa96565515a7160f439cadcd51482c41e9
Computational	Neighborhood of CDH11	LAMB1 LAMC1 THBS2 LOXL2	1.16e-05	25	62	4	GNF2_CDH11
Computational	Neighborhood of PTX3	LAMB1 LAMC1 THBS2 LOXL2	5.15e-05	36	62	4	GNF2_PTX3
Computational	Neighborhood of SPINK1	CTRC CUZD1 GP2	4.84e-04	27	62	3	GNF2_SPINK1
Drug	AC1L1G72	LAMA4 LAMB1 LAMC1 LAMC2	1.54e-07	11	108	4	CID000003553
Drug	BM165	LAMA4 LAMB1 LAMC1 LAMC2	1.54e-07	11	108	4	CID003352881
Drug	poly-N-acetyllactosamine	LAMA4 LAMB1 NEU3 LAMC1 LAMC2 STS GP2	2.06e-07	88	108	7	CID000119547
Drug	AC1L9INI	HSPG2 DSG1 LAMA4 LAMB1 LAMC1 LAMC2	3.64e-07	59	108	6	CID000445839
Drug	LMWH	HSPG2 ADAM9 CTRC LAMA4 LAMB1 NEU3 LAMC1 LAMC2 ADCY5 THBS1 THBS2 THBS3 LIPG KLK13 AGRN	5.61e-07	663	108	15	CID000000772
Drug	chondroitin sulfate	HSPG2 IMPG1 LAMA4 LAMB1 NEU3 LAMC1 LAMC2 THBS1 THBS2 THBS3 STS AGRN	6.29e-07	413	108	12	CID000024766
Drug	dysprosium	CTRC LAMA4 LAMB1 LAMC1 LAMC2 AGRN	1.41e-06	74	108	6	CID000023912
Drug	DB04780	LAMA4 LAMB1 NEU3 LAMC1 LAMC2 THBS1 STS KLK13	1.53e-06	170	108	8	CID005459389
Drug	quinaprilat	CTRC LAMA4 LAMB1 LAMC1 LAMC2	1.82e-06	43	108	5	CID000107994
Drug	Rgd Peptide	ADGRB2 LAMA4 LAMB1 LAMC1 LAMC2 GCDH THBS1 THBS2 THBS3	2.11e-06	239	108	9	CID000104802
Drug	ALT-711	LAMA4 LAMB1 LAMC1 LAMC2	2.69e-06	21	108	4	CID000216304
Drug	Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	CACNA2D1 NEU3 SUCLG1 STS HPN RECQL5 LILRA4 BAHCC1	4.41e-06	196	108	8	3369_UP
Drug	Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	HSPG2 IMPG1 LAMC2 SUCLG1 SLC10A1 KLK13 NOS2 GP2	4.58e-06	197	108	8	4143_UP
Drug	Sikvav	LAMA4 LAMB1 LAMC1 LAMC2	4.73e-06	24	108	4	CID005487517
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A	CACNA2D1 CLSTN3 LAMA4 LAMC2 MELTF STS KLHDC8A LILRA4	4.75e-06	198	108	8	4158_UP
Drug	2,4-diaminopyrimidine	LAMA4 LAMB1 LAMC1 LAMC2 AGRN	5.75e-06	54	108	5	CID000067431
Drug	kalinin	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2	6.30e-06	55	108	5	CID000032518
Drug	CC270	CENPB LAMA4 LAMB1 LAMC1 LAMC2	8.93e-06	59	108	5	CID006918852
Drug	LG 5	LAMA4 LAMB1 LAMC1 LAMC2 AGRN	9.71e-06	60	108	5	CID011840957
Drug	sulfate	HSPG2 CACNA2D1 FBLN7 CTRC LAMA4 LAMB1 NEU3 LAMC1 LAMC2 SUCLG1 DLL1 THBS1 THBS2 THBS3 STS LIPG TAF1 NOS2 AGRN	9.77e-06	1292	108	19	CID000001117
Drug	AC1L1B58	LAMA4 LAMB1 LAMC1 LAMC2	1.04e-05	29	108	4	CID000001288
Drug	Rgds Peptide	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2	1.15e-05	106	108	6	CID000107775
Drug	Gdrgdsp	LAMA4 LAMB1 LAMC1 LAMC2 HPDL THBS1	1.35e-05	109	108	6	CID000115346
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	GALNT12 IRS1 THBS1 THBS3 SF3B3 AP4M1 EPHA1	2.63e-05	182	108	7	1231_DN
Drug	2-phenylindole	STS TAF1 TAF1L	2.87e-05	13	108	3	CID000013698
Drug	Calcort	LAMA4 LAMB1 LAMC1 LAMC2	3.12e-05	38	108	4	CID000026709
Drug	Ikvav	LAMA4 LAMB1 LAMC1 LAMC2	3.12e-05	38	108	4	CID000131343
Drug	2-amino-5-methylpyridine	LAMA4 LAMB1 LAMC1 LAMC2 AGRN	3.29e-05	77	108	5	CID000015348
Drug	YIGSR	LAMA4 LAMB1 LAMC1 LAMC2 RCC1	3.73e-05	79	108	5	CID000123977
Drug	chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A	CACNA2D1 FSCN3 LAMA4 RCC1 NRXN3 KLHDC8A MYBPC3	3.95e-05	194	108	7	4441_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	CLSTN3 CUBN THBS1 SLC10A1 STS CUZD1 KLK13	4.08e-05	195	108	7	3829_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	HSPG2 FSCN3 ETV2 CRTAC1 THBS3 EPHA1 RAB11FIP3	4.08e-05	195	108	7	4792_UP
Drug	Nadide [53-84-9]; Up 200; 6uM; HL60; HT_HG-U133A	CACNA2D1 SMURF1 NEU3 THBS1 MELTF RECQL5 EPHA1	4.08e-05	195	108	7	2529_UP
Drug	AC1L1I54	CACNA2D1 MCHR1 DLL1 ADCY5	4.24e-05	41	108	4	CID000004426
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A	SMURF1 RCC1 THBS3 SF3B3 STS PRRC2B RAB11FIP3	4.35e-05	197	108	7	2093_DN
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	HSPG2 TNFRSF11A SUCLG1 THBS1 KLHDC8A RECQL5 ZNF646	4.35e-05	197	108	7	3098_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	HSPG2 LAMA4 HKDC1 STS HPN KLK13 LILRA4	4.35e-05	197	108	7	5250_UP
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	LAMA4 LAMC2 THBS1 NRXN3 STS RECQL5 CUZD1	4.35e-05	197	108	7	5664_UP
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; PC3; HT_HG-U133A	CACNA2D1 ADGRB2 LAMC2 PPARGC1B SF3B3 LIPG MYBPC3	4.49e-05	198	108	7	6749_UP
Drug	Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	LAMC2 RCC1 STS ENTPD5 TAF1 EPHA1 ZNF646	4.64e-05	199	108	7	6505_UP
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A	SMURF1 GCDH NRXN3 CUZD1 KLK13 BAHCC1 RAB11FIP3	4.64e-05	199	108	7	5857_UP
Drug	Grgds	LAMA4 LAMB1 LAMC1 LAMC2 THBS1	4.73e-05	83	108	5	CID000123811
Drug	2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine	LAMA4 LAMB1 LAMC1 LAMC2 THBS1	4.73e-05	83	108	5	CID011968896
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; PC3; HT_HG-U133A	ADGRB2 LAMC2 RCC1 NRXN3 STS KLK13 LILRA4	4.79e-05	200	108	7	6620_UP
Drug	NSC 714187	DSG1 LAMA4 LAMB1 LAMC1 LAMC2	5.31e-05	85	108	5	CID005288693
Drug	trypanothione disulfide	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 THBS2	5.55e-05	140	108	6	CID000115098
Drug	Mfpa	TAF1 TAF1L	6.67e-05	3	108	2	CID003035615
Drug	AC1MIYVS	DLL1 TRIM9	6.67e-05	3	108	2	CID003082459
Drug	dl-Lysine	LAMA4 LAMB1 LAMC1 LAMC2 GCDH SUCLG1 ADCY5 NOS2	7.36e-05	290	108	8	CID000000866
Drug	dermatan sulfate	HSPG2 LAMA4 LAMB1 NEU3 LAMC1 LAMC2 STS	8.72e-05	220	108	7	CID000032756
Drug	Nor 3	THBS1 THBS2 THBS3 NOS2	9.32e-05	50	108	4	CID009578441
Drug	GTP - Na	ADCY10 CACNA2D1 MCHR1 LAMA4 LAMB1 LAMC1 LAMC2 RCC1 IRS1 SUCLG1 ADCY5 ARF6 TAF1 NOS2	1.19e-04	923	108	14	CID000000762
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	ADAM9 LAMB1 LAMC1 THBS1 LOXL2 AGRN	1.20e-04	161	108	6	3556_DN
Drug	estrone sulfate	GCDH TNFRSF11A THBS1 SLC10A1 STS NOS2	1.29e-04	163	108	6	CID000000699
Drug	2,3-Diphosphoglycerate	ARF6 STS	1.33e-04	4	108	2	ctd:D019794
Drug	NSC-116341	CACNA2D1 DLL1	1.33e-04	4	108	2	CID000097337
Drug	3-butylpiperidine	GCDH STS	1.33e-04	4	108	2	CID004630072
Drug	Fenoldopam	ADAM9 THBS1 LOXL2 NOS2	1.78e-04	59	108	4	ctd:D018818
Drug	PD-0200347	CACNA2D1 NOS2	2.21e-04	5	108	2	ctd:C497431
Drug	ethyl ethanimidate	ASRGL1 STS LIPG	2.49e-04	26	108	3	CID000065066
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	HSPG2 ADGRB2 CHD7 RECQL5 ENTPD5 BAHCC1	2.56e-04	185	108	6	4327_DN
Drug	AC1O0B8G	LAMA4 LAMB1 LAMC1 LAMC2 THBS1 NOS2 AGRN	2.56e-04	262	108	7	CID000091605
Drug	hyaluronan	HSPG2 LAMA4 LAMB1 LAMC1 LAMC2 TNFRSF11A EPHA1	2.62e-04	263	108	7	CID000024759
Drug	C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA	IMPG1 ADGRB2 LAMA4 NEU3 TNFRSF11A RECQL5	2.79e-04	188	108	6	865_UP
Drug	eniluracil	CACNA2D1 MCHR1 CTRC	2.79e-04	27	108	3	CID000043157
Drug	TTNPB; Up 200; 0.1uM; MCF7; HG-U133A	CACNA2D1 CLSTN3 ABCA4 RCC1 TRIM9 LOXL2	2.95e-04	190	108	6	223_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	RCC1 LAX1 THBS1 TAF1 AP4M1 BAHCC1	2.95e-04	190	108	6	1150_DN
Drug	Domperidone maleate; Up 200; 7.4uM; PC3; HT_HG-U133A	CLSTN3 IMPG1 SMURF1 RCC1 THBS1 NRXN3	3.03e-04	191	108	6	4640_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	LAMA4 NEU3 RCC1 NRXN3 STS KLHDC8A	3.21e-04	193	108	6	3811_UP
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; HL60; HT_HG-U133A	THBS1 STS SV2A RECQL5 ENTPD5 AGRN	3.21e-04	193	108	6	2933_UP
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	LAMB1 GCDH RCC1 THBS1 LOXL2 AP4M1	3.30e-04	194	108	6	5316_DN
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	IMPG1 FSCN3 LAMA4 LAMC2 STS KLK13	3.30e-04	194	108	6	4951_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A	LAMC2 RCC1 THBS3 STS LIPG BAHCC1	3.30e-04	194	108	6	6660_DN
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; PC3; HT_HG-U133A	ADGRB2 CTRC LAMC2 CD5L LIPG GP2	3.30e-04	194	108	6	6738_UP
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	HSPG2 CENPB ADGRB2 RECQL5 EPHA1 RAB11FIP3	3.30e-04	194	108	6	4325_DN
Drug	High Fructose Corn Syrup	IRS1 NOS2	3.30e-04	6	108	2	ctd:D066248
Drug	Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; HL60; HG-U133A	SMURF1 LAMC1 SLC10A1 AP4M1 PRRC2B GP2	3.39e-04	195	108	6	1731_UP
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	HSPG2 FSCN3 NEU3 THBS1 STS MYBPC3	3.39e-04	195	108	6	4107_UP
Drug	Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A	MELTF NRXN3 SLC10A1 STS KLK13 ZNF646	3.39e-04	195	108	6	3613_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	SMURF1 RCC1 CHD7 RECQL5 CUZD1 TAF1	3.39e-04	195	108	6	4019_DN
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A	CACNA2D1 ADGRB2 SUCLG1 MELTF NRXN3 RAB11FIP3	3.39e-04	195	108	6	6379_UP
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	NEU3 RCC1 THBS1 MELTF STS CUZD1	3.39e-04	195	108	6	3860_UP
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ADGRB2 LAMC2 RCC1 STS RECQL5 TAF1	3.39e-04	195	108	6	5330_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	CLSTN3 STS CUZD1 TAF1 BAHCC1 RAB11FIP3	3.39e-04	195	108	6	3721_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	CLSTN3 IMPG1 THBS1 STS GP2 MYBPC3	3.39e-04	195	108	6	3634_UP
Drug	2-amino-4,6-dinitrotoluene	HSPG2 LAMB1 LAMC2 ENTPD5	3.45e-04	70	108	4	ctd:C035208
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HT_HG-U133A	FSCN3 RCC1 MELTF STS CUZD1 KLK13	3.48e-04	196	108	6	6313_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	CLSTN3 SMURF1 LAX1 MELTF TRIM9 ENTPD5	3.48e-04	196	108	6	3742_DN
Drug	Acetaminophen [103-90-2]; Up 200; 26.4uM; HL60; HT_HG-U133A	ADCY10 THSD7A IMPG1 LAMA4 PPARGC1B NRXN3	3.48e-04	196	108	6	3025_UP
Drug	CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A	FSCN3 CTRC STS LOXL2 ENTPD5 BAHCC1	3.48e-04	196	108	6	7512_UP
Drug	retinoic acid; Down 200; 1uM; HL60; HG-U133A	NEU3 LAMC2 CUBN PRRC2B BAHCC1 GP2	3.48e-04	196	108	6	390_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	LAMC2 SUCLG1 THBS1 STS GP2 MYBPC3	3.48e-04	196	108	6	5593_UP
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	CACNA2D1 LAMA4 CRTAC1 STS LOXL2 KLK13	3.48e-04	196	108	6	3971_UP
Drug	Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A	RCC1 THBS1 THBS3 HPN BAHCC1 GP2	3.48e-04	196	108	6	4958_UP
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	NEU3 LAMC2 SUCLG1 CUZD1 KLK13 BAHCC1	3.48e-04	196	108	6	2306_UP
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	HSPG2 SMURF1 LAMA4 LAMC2 THBS3 NRXN3	3.48e-04	196	108	6	6673_DN
Drug	Iopromide [73334-07-3]; Up 200; 5uM; PC3; HT_HG-U133A	HSPG2 CLSTN3 STS LOXL2 RECQL5 CUZD1	3.58e-04	197	108	6	4504_UP
Drug	Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A	CLSTN3 LAX1 STS KLK13 GP2 ZNF646	3.58e-04	197	108	6	4408_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	CACNA2D1 FSCN3 CRTAC1 NRXN3 LIPG HPN	3.58e-04	197	108	6	6708_UP
Drug	Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A	NEU3 RCC1 LAX1 MELTF KLK13 RAB11FIP3	3.58e-04	197	108	6	3815_UP
Disease	laminin subunit gamma-2 measurement	LAMC1 LAMC2	1.33e-05	2	108	2	EFO_0801756
Disease	albuminuria	PAPLN CHD7 CUBN BAHCC1	4.02e-04	94	108	4	EFO_0004285
Disease	body height at birth	HKDC1 ADCY5 SV2A	4.27e-04	40	108	3	EFO_0006784
Disease	retinitis pigmentosa (is_implicated_in)	ABCA4 IMPG1 HKDC1	4.59e-04	41	108	3	DOID:10584 (is_implicated_in)
Disease	Marfan Syndrome, Type I	LAMC1 NOS2	4.70e-04	9	108	2	C4721845
Disease	coronary artery disease (is_implicated_in)	IRS1 C1orf167 CUBN LIPG	5.08e-04	100	108	4	DOID:3393 (is_implicated_in)
Disease	corpus callosum volume measurement	CACNA2D1 LAMC1 LAMC2 DLL1	5.08e-04	100	108	4	EFO_0010299
Disease	urinary albumin to creatinine ratio	CHD7 CUBN THBS3 HPN BAHCC1	5.23e-04	179	108	5	EFO_0007778
Disease	TPE interval measurement, response to exercise	NOL4L NRXN3	5.86e-04	10	108	2	EFO_0004644, EFO_0007768
Disease	Marfan Syndrome	LAMC1 NOS2	7.14e-04	11	108	2	C0024796
Disease	sleep apnea measurement	ASB15 LAX1 KCNA4 SCN3A	8.87e-04	116	108	4	EFO_0007817
Disease	glutaroyl carnitine measurement	ACADM GCDH	1.01e-03	13	108	2	EFO_0021005
Disease	non-high density lipoprotein cholesterol measurement	LAMC1 LAMC2 HEATR5A CHD7 THBS3 CMIP KCNA4 LIPG GLTPD2	1.25e-03	713	108	9	EFO_0005689
Disease	Diabetes Mellitus, Non-Insulin-Dependent	IRS1 ADCY5 CMIP NOS2 GP2	1.34e-03	221	108	5	C0011860
Disease	Diabetic Angiopathies	THBS1 THBS2	1.54e-03	16	108	2	C0011875
Disease	Microangiopathy, Diabetic	THBS1 THBS2	1.54e-03	16	108	2	C0025945
Disease	Sjogren's syndrome (implicated_via_orthology)	MUC19 THBS1	1.74e-03	17	108	2	DOID:12894 (implicated_via_orthology)
Disease	Necrotizing Enterocolitis	ACADM NOS2	1.74e-03	17	108	2	C0520459
Disease	Lipidemias	IRS1 PPARGC1B	1.74e-03	17	108	2	C1706412
Disease	Hyperlipidemia	IRS1 PPARGC1B	1.74e-03	17	108	2	C0020473
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACADM IRS1 PPARGC1B	1.77e-03	65	108	3	DOID:0080208 (biomarker_via_orthology)
Disease	susceptibility to vaginal yeast infection measurement	FBLN7 DSG1 TEX2	1.77e-03	65	108	3	EFO_0008412
Disease	platelet component distribution width	CRTAC1 IRS1 DUSP19 CUBN ADCY5 MELTF NOL4L METTL13 RAB11FIP3	1.84e-03	755	108	9	EFO_0007984
Disease	Hypertriglyceridemia	LAMC1 LAMC2	2.18e-03	19	108	2	EFO_0004211
Disease	anorectal malformation	CSMD2 THBS2	2.18e-03	19	108	2	MONDO_0019938
Disease	autism spectrum disorder (implicated_via_orthology)	LAMC1 LAMC2 CHD7 NRXN3	2.40e-03	152	108	4	DOID:0060041 (implicated_via_orthology)
Disease	alpha-tocopherol measurement	CACNA2D1 SCN3A	2.42e-03	20	108	2	EFO_0007898
Disease	epilepsy (implicated_via_orthology)	KCNA4 SV2A SCN3A NOS2	3.08e-03	163	108	4	DOID:1826 (implicated_via_orthology)
Disease	arginine measurement	LAMC2 GCDH	3.19e-03	23	108	2	EFO_0020990

Protein segments in the cluster

Peptide	Gene	Start	Entry
GTQGYPCEGTGEEVK	ADGRB2	506	O60241
RCHCEPGYEEGGSGE	EPHA1	261	P21709
PGYEEGGSGEACVAC	EPHA1	266	P21709
GSGYDSEDCEGLLGT	BAHCC1	1651	Q9P281
CLYPGNVVRGASGDE	BAHCC1	1991	Q9P281
GREAVYTAGPGACGL	C1orf167	746	Q5SNV9
TFTIQAYDCGEGPDG	CLSTN3	106	Q9BQT9
ASYEEIEQGSCGDPG	CSMD2	511	Q7Z408
DLLCGYPEGGGSRVL	ABCA4	321	P78363
RVGDSPCLGAGGYAD	ASRGL1	196	Q7L266
PCLGAGGYADNDIGA	ASRGL1	201	Q7L266
NPGALGASEDSGGLY	CARMIL2	346	Q6F5E8
EGTVCGSDGADYPGE	AGRN	281	O00468
GSDGADYPGECQLLR	AGRN	286	O00468
PDCISLLLEYGGSGN	ASB15	256	Q8WXK1
FQLYSPGGVACDDDG	CMIP	526	Q8IY22
GCGAASGTPSGILYE	CD5L	66	O43866
PEGGLGYSQLGDDDL	CDK11B	756	P21127
IPENCGGLGLGTFDA	ACADM	91	P11310
GDYEVEPGCGGERNA	ADCY5	616	O95622
ELDSYLGEGSCGIPF	ADCY10	721	Q96PN6
SQERPGAIGLDGCYS	ANKRD52	1061	Q8NB46
IFSEGLEGLGECGYP	CHD7	16	Q9P2D1
LATLLGDYCGSLGEG	AP4M1	86	O00189
GDYCGSLGEGTISRN	AP4M1	91	O00189
GDLYTLGCGEQGQLG	RCC1	191	P18754
DSGEYVCRVENGSGP	HSPG2	2111	P98160
IRNGDPDGQCYGGVA	RAB11FIP3	266	O75154
GDSGGPLVCNRTLYG	KLK13	216	Q9UKR3
GCSVGGASGLVEVDY	MSGN1	81	A6NI15
ELSCEDGQGLNYLPG	NOS2	756	P35228
PGGYRTLADGKSCED	FBLN7	256	Q53RD9
EPRYCSGLGAGTAQD	KRBA1	706	A5PL33
PGENLTLQCGSDVGY	LILRA4	236	P59901
GGNQEGEVGFEPCYA	ENTPD5	291	O75356
GGPDAGVQCSDAYRA	GLTPD2	206	A6NH11
TEGLLAPVGACEGDY	MST1L	651	Q2TV78
SGPLEACYGELGQSR	MTMR10	701	Q9NXD2
YDSQGSLDGLEPGLC	IMPG1	716	Q17R60
EDVACPQGGVQYGAG	LOXL2	526	Q9Y4K0
GQYQSCGECLGSGDP	PLXNA4	511	Q9HCM2
SGCTCPEGYLLDDIG	MUC19	751	Q7Z5P9
SYGLDLDCGAPGTPE	GP2	41	P55259
GSDGCDDDGLVISGY	NRXN3	1396	Q9Y4C0
GDAGDCTSLYSPGAE	LAX1	236	Q8IWV1
GDFQPGCGLNDVLGS	LIPG	246	Q9Y5X9
AEGSCYPATGDLLIG	LAMB1	31	P07942
GLGEAGEDLSYGDVP	IRS1	141	P35568
LGTASYPSDGCGADG	NOL4L	101	Q96MY1
YDIEGVGSPAGSVGC	DSG1	721	Q02413
YPEGGIDACQGDSGG	HPN	341	P05981
VNEGAGSGEPLYGLD	HPDL	56	Q96IR7
PGALGNGTYKGEDCS	SLC10A1	331	Q14973
YPEGRRDTCQGDSGG	PRSS36	231	Q5K4E3
LRCGGNYTDPEGELF	CUBN	706	O60494
YDFLPDQAAGLCGGD	CENPB	201	P07199
LLGNGVACGSLEYDP	HEATR5A	741	Q86XA9
DGVISACNGDSGGPL	CTRC	206	Q99895
GELLGCFGLTEPNSG	GCDH	171	Q92947
EDYTDCGGVSGLNPS	CACNA2D1	1066	P54289
FNGGRCSDSPDGGYS	DLL1	376	O00548
SYLALPGGGDCSDTG	FAM83C	361	Q9BQN1
ALCDGEGGMLYPQGT	FSCN3	226	Q9NQT6
EYLGNSGEPQIGGFD	GALNT12	266	Q8IXK2
PNCETKGYGGSVDSG	ADAM9	671	Q13443
LGGGSGCQATEEDPL	MCHR1	16	Q99705
GQVYAIGGCDDNGVP	KLHDC8A	31	Q8IYD2
LCDDGYFGDPLGRNG	LAMC1	806	P11047
GGACDPDTGDCYSGD	LAMC2	421	Q13753
YEPNEDGTACVGTLG	CRTAC1	596	Q9NQ79
IPNCGGYLDTLEGSF	CUZD1	151	Q86UP6
IASLAGGGEARPCYD	METTL13	556	Q8N6R0
SLAYPDCAGGGRGAE	ETV2	326	O00321
GRDGCEYSLGLTPTG	EPB41L4B	281	Q9H329
EQTETLGVGYGCPED	LAMA4	1216	Q16363
TLACLGPGEYAEGVS	GAREM2	31	Q75VX8
YGACVEEEGALTGGP	RTKN	196	Q9BST9
QGLGDYCEGPRAQGE	SSPOP	3286	A2VEC9
DYFGGSCVPGAGETS	MELTF	166	P08582
LAYAGEEGGIRCPNS	THSD7A	666	Q9UPZ6
YEDPNCEIGLIAGTG	HKDC1	666	Q2TB90
AGGDSGLEAQYTCPI	RNF166	21	Q96A37
GVADPTGCGEGFSYV	TAF1L	971	Q8IZX4
TGVADPTGCGEGFSY	TAF1	951	P21675
SDGCDDDGLVISGYG	NRXN3	391	Q9HDB5
GVAEGPGAELSLCYQ	PIK3R6	581	Q5UE93
QGGGSGEEQLYADFP	PPARGC1B	26	Q86YN6
DLGIGDPGCYGNKTI	STS	36	P08842
LCGNGSDAGQCPEGY	SCN3A	336	Q9NY46
PYTDSTGAAAGGGNC	SMURF1	181	Q9HCE7
SLCVGIGGDPFNGTD	SUCLG1	221	P53597
EGCPLDVTGTGEGAY	SV2A	581	Q7L0J3
VQPSCATSGDGLYEG	ARF6	151	P62330
GPCGYSDLAALEEEG	NEU3	366	Q9UQ49
SQGNGFDPELYEGGR	RECQL5	461	O94762
NYGENLCYGDSGGPL	PRSS45P	176	Q7RTY3
LCYGDSGGPLACEVE	PRSS45P	181	Q7RTY3
GYAGNGIICGEDTDL	THBS1	681	P07996
GGDSGPEEDYLSLGA	SYNPO2	726	Q9UMS6
GGDGTTCYPVAGTFD	PAPLN	176	O95428
GDRPSLALYSCGGEG	GEMIN5	491	Q8TEQ6
EGAGTPLGDSLCIQG	ZNF646	1026	O15015
YGSAIIENCGSSPGE	PRRC2B	1536	Q5JSZ5
NGNVCGTDTDIDGYP	THBS3	451	P49746
GSDGPSGVLICSENY	SF3B3	241	Q15393
PADGYILELDDGNGG	TRIM9	471	Q9C026
SLVEGTGLACDPFGG	ZNF316	641	A6NFI3
QTGYAGDGLICGEDS	THBS2	681	P35442
YSVLCSGALGAGGDQ	VSIG10L	651	Q86VR7
CDSEGDGYGSDSNIP	TEX2	351	Q8IWB9
TCVGGGPYAQGEDAR	TNFRSF11A	311	Q9Y6Q6
YHSQDDGPGLEGGDC	VWA5B1	606	Q5TIE3
VEPSSGGGCGYVQDL	DUSP19	46	Q8WTR2
CSYTDLLPQDEGGGG	KCNA4	151	P22459
VGAGGLDGYSVEYCP	MYBPC3	896	Q14896